about
State-of-the-art human gene therapy: part I. Gene delivery technologiesGeneral considerations on the biosafety of virus-derived vectors used in gene therapy and vaccinationA herpes simplex virus-derived replicative vector expressing LIF limits experimental demyelinating disease and modulates autoimmunityCRF-amplified neuronal TLR4/MCP-1 signaling regulates alcohol self-administration.Construction of Various γ34.5 Deleted Fluorescent-Expressing Oncolytic herpes Simplex type 1 (oHSV) for Generation and Isolation of HSV-Based VectorsAn attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challengeEvaluation of infectious titer in a candidate HSV type 2 vaccine by a quantitative molecular approach.Oncolytic herpes simplex virus 1 encoding 15-prostaglandin dehydrogenase mitigates immune suppression and reduces ectopic primary and metastatic breast cancer in mice.Enhanced antitumor efficacy of an oncolytic herpes simplex virus expressing an endostatin-angiostatin fusion gene in human glioblastoma stem cell xenografts.Advances in Gene Delivery Systems.Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virusEfficient gene delivery and selective transduction of astrocytes in the mammalian brain using viral vectors.Oncolytic herpes viruses, chemotherapeutics, and other cancer drugsToxicology and Biodistribution Studies for MGH2.1, an Oncolytic Virus that Expresses Two Prodrug-activating Genes, in Combination with ProdrugsIn vitro Inactivation of Latent HSV by Targeted Mutagenesis Using an HSV-specific Homing EndonucleaseRetargeting of viruses to generate oncolytic agents.Pancreatic cancer gene therapy: from molecular targets to delivery systems.The herpes viral transcription factor ICP4 forms a novel DNA recognition complex.Gene Delivery Approaches for Mesenchymal Stem Cell Therapy: Strategies to Increase Efficiency and Specificity.Adenovirus-Mediated Gene Delivery: Potential Applications for Gene and Cell-Based Therapies in the New Era of Personalized Medicine.CEP290 gene transfer rescues Leber congenital amaurosis cellular phenotype.Gene therapy with HSV encoding p55TNFR gene for HIV neuropathic pain: an evidence-based mini-review.Innately activated TLR4 signal in the nucleus accumbens is sustained by CRF amplification loop and regulates impulsivity.The GABAA Receptor α2 Subunit Activates a Neuronal TLR4 Signal in the Ventral Tegmental Area that Regulates Alcohol and Nicotine Abuse.
P2860
Q26825575-30700183-F2C3-4989-A69C-0EECA4E61BA0Q26850701-0F6D29B3-B5CA-412D-9671-AB34C68B3FFDQ27319470-6EABAB56-4213-4A35-B065-8E96D3A72D9EQ30384806-ADB3F7A2-DCCF-4336-94B7-F1F189892D0BQ33766379-F15EC377-193E-456E-9B56-369DCA249D87Q33916162-B269BE31-6E35-4C94-B512-D45CE6841F77Q35061783-F506E8FD-96E7-4B77-A950-866F666D9885Q35077655-79931F64-13C2-442A-A4C3-9497FC58E176Q35155160-03E64E94-69BE-48EE-B55B-F9E2977846A1Q35632772-C65665B9-4D52-4142-8AEA-077ED05F7BD4Q36659325-A18F526D-BCE4-4C40-8CEF-06851D8338F4Q36983576-1CF688F8-F00A-43AE-B436-118436DB018DQ37031896-82FB5A6D-9173-47B6-B5AA-3922CB5EF6ECQ37138701-9DF97167-58F7-476B-9897-E1EE7A218036Q37634060-CFFD9CA0-DAD5-49F0-865C-94649283F514Q37982062-EFD90BA3-013B-4180-AD8C-3F4BCDDA8542Q38161331-DB54AF9C-B111-41B5-AD06-B5B9B168C093Q38785758-C83FDE13-FFC4-4C50-B0BA-2C94A04524A7Q40080450-722B5A28-1E6F-4638-8D66-D43A77573979Q41699782-4642D290-8AEA-4FB8-A125-F49A471E35FAQ42051635-3502A2B9-6267-4FFE-91B2-996E85A7F2CEQ45874354-9826757F-ADF1-4BA3-9F1F-616223F1767AQ47577664-C06EC13A-5989-4926-BA96-9D46F7935105Q53402920-8609B33E-75D7-4C7A-8F3E-B48903481634
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HSV Recombinant Vectors for Gene Therapy.
@en
HSV Recombinant Vectors for Gene Therapy.
@nl
type
label
HSV Recombinant Vectors for Gene Therapy.
@en
HSV Recombinant Vectors for Gene Therapy.
@nl
prefLabel
HSV Recombinant Vectors for Gene Therapy.
@en
HSV Recombinant Vectors for Gene Therapy.
@nl
P2093
P2860
P1476
HSV Recombinant Vectors for Gene Therapy.
@en
P2093
Peggy Marconi
Rafaela Argnani
Roberto Manservigi
P2860
P304
P356
10.2174/1874357901004010123
P577
2010-06-18T00:00:00Z